Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 7/20 | 0.44 |
| ▸ | NPC1 | O15118 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | PRNP | P04156 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 2/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27538848 | 0.98 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| Hydrazine SCHEMBL27575629 | 0.96 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| SCHEMBL29737639 | 0.74 | PDPK1 (0.46) | ALDH1A1HSD17B10RAB9AHPGDKMT2A | |
| SCHEMBL2682744 | 0.74 | ALDH1A1 (0.45) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| SCHEMBL29967087 | 0.74 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| SCHEMBL288904 | 0.74 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| SCHEMBL2088376 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10RAB9ANPC1KDM4E | |
| SCHEMBL197613 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10MAPTL3MBTL1HTR1A | |
| SCHEMBL926998 | 0.74 | LMNA (0.46) | SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1 | |
| SCHEMBL288903 | 0.74 | ALDH1A1 (0.45) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3972596-B1 | COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES | PFIZER (US) | 2025-07-16 | — | — | EP | claimed |
| EP-3704113-B1 | BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2023059867-A1 | COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-04-13 | — | — | WO | claimed |
| EP-3704114-B1 | SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2022-11-23 | — | — | EP | claimed |
| EP-3681881-B1 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC MUTAGENIC AND FIBROTIC CONDITIONS AND DISORDERS | ARDELYX INC (US) | 2022-11-02 | — | — | EP | claimed |
| CN-111632594-A | Method for regulating and controlling surface plasmon photocatalysis and application | 南京工业大学 | 2020-09-08 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| US-12545671-B2 | Compound having biological activity such as antiviral activity | NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE (JP) | 2026-02-10 | — | — | US | disclosed |
| US-20250320201-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | AGIOS PHARMACEUTICALS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250171438-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | AGIOS PHARMACEUTICALS, INC. | 2025-05-29 | — | — | US | disclosed |
| CN-119798326-A | Benzothiazole phosphorus compound and synthetic method and application thereof | 江西师范大学 | 2025-04-11 | — | — | CN | disclosed |
| US-20240246951-A1 | COMPOUND HAVING BIOLOGICAL ACTIVITY SUCH AS ANTIVIRAL ACTIVITY | NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE (JP) | 2024-07-25 | — | — | US | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-5861424-A | CATIONIC HETEROCYCLIC COMPOUNDS FOR TREATING CANCER | DANA FARBER CANCER INSTITUTE (US) | 1999-01-19 | — | — | US | disclosed |
| US-5670530-A | ADJUSTMENT SOLUBILITY OF RHODACYANINE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| EP-0527494-B1 | Compositon containing rhodacyanine dyes for treating cancer | FUJI PHOTO FILM CO LTD (JP) | 1996-11-06 | — | — | EP | disclosed |
| US-5360803-A | Rhodocyanine dyes | DAN FARBER CANCER INSTITUTE (US) | 1994-11-01 | — | — | US | disclosed |
| CN-1071834-A | The compositions and the method for treatment cancer | FUJI PHOTO FILM CO LTD (JP) | 1993-05-12 | — | — | CN | disclosed |
| EP-0527494-A1 | Compositon containing rhodacyanine dyes for treating cancer | Fuji Photo Film Co., Ltd. (JP) | 1993-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545671-B2 | Compound having biological activity such as antiviral activity | SARS1, ACE2, ACE | SMN1; SMN2 1097/4885ALDH1A1 2867/4885HSD17B10 2602/4885 |
| US-20240246951-A1 | COMPOUND HAVING BIOLOGICAL ACTIVITY SUCH AS ANTIVIRAL ACTIVITY | RNASE1, ZC3HAV1, ACE | SMN1; SMN2 2652/4885ALDH1A1 1459/4885HSD17B10 2409/4885 |
| US-20250320201-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | PAH, KDM8, PHF8 | SMN1; SMN2 1592/4885ALDH1A1 865/4885HSD17B10 1477/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | SMN1; SMN2 4265/4885ALDH1A1 4757/4885HSD17B10 4363/4885 |
| US-20250171438-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | PAH, KDM8, PHF8 | SMN1; SMN2 1592/4885ALDH1A1 865/4885HSD17B10 1477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.